Latest Insider Transactions at Alx Oncology Holdings Inc (ALXO)
This section provides a real-time view of insider transactions for Alx Oncology Holdings Inc (ALXO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALX ONCOLOGY HOLDINGS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALX ONCOLOGY HOLDINGS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,700
+2.86%
|
$16,700
$1.91 P/Share
|
|
Mar 10
2021
|
Sophia Randolph CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,387
-0.89%
|
$546,638
$74.9 P/Share
|
|
Jan 28
2021
|
Peter S Garcia CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,128
+40.17%
|
$24,512
$4.08 P/Share
|
|
Jan 26
2021
|
Jaume Pons PRESIDENT & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.78%
|
$0
$0.99 P/Share
|
|
Dec 14
2020
|
G. Walmsley Graham Director |
BUY
Open market or private purchase
|
Indirect |
20,000
+1.97%
|
$1,520,000
$76.0 P/Share
|